BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12572844)

  • 1. Endothelial markers and homocysteine in patients with classic Fabry disease.
    Demuth K; Germain DP
    Acta Paediatr Suppl; 2002; 91(439):57-61. PubMed ID: 12572844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between homocysteine and endothelial dysfunction markers in stroke disease.
    Abdulle AM; Pathan JY; Moussa N; Gariballa S
    Nutr Neurosci; 2010 Feb; 13(1):2-6. PubMed ID: 20132648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profile of endothelial and leukocyte activation in Fabry patients.
    DeGraba T; Azhar S; Dignat-George F; Brown E; Boutière B; Altarescu G; McCarron R; Schiffmann R
    Ann Neurol; 2000 Feb; 47(2):229-33. PubMed ID: 10665494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease.
    Tsakiris DA; Tschöpl M; Jäger K; Haefeli WE; Wolf F; Marbet GA
    Atherosclerosis; 1999 Jan; 142(1):193-200. PubMed ID: 9920521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin.
    Peter K; Nawroth P; Conradt C; Nordt T; Weiss T; Boehme M; Wunsch A; Allenberg J; Kübler W; Bode C
    Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):505-12. PubMed ID: 9102169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of thrombomodulin, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin in the acute phase of Plasmodium vivax malaria.
    Ohnishi K
    Am J Trop Med Hyg; 1999 Feb; 60(2):248-50. PubMed ID: 10072144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease in circulating endothelial cell adhesion molecule and thrombomodulin levels during oral iloprost treatment in rheumatoid arthritis patients: preliminary results.
    Boehme MW; Gao IK; Norden C; Lemmel EM
    Rheumatol Int; 2006 Feb; 26(4):340-7. PubMed ID: 15700117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anderson-Fabry disease: a multiorgan disease.
    Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Pinto A; Licata G
    Curr Pharm Des; 2013; 19(33):5974-96. PubMed ID: 23448451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term hormone replacement therapy: reduced plasma levels of soluble adhesion molecules.
    Van Baal WM; Emeis JJ; Kenemans P; Kessel H; Peters-Muller ER; Schalkwijk CG; van der Mooren MJ; Stehouwer CD
    Eur J Clin Invest; 1999 Nov; 29(11):913-21. PubMed ID: 10583435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examination of adhesion molecules, homocysteine and hs-CRP in patients with polygenic hypercholesterolemia and isolated hypertriglyceridemia.
    Calan M; Calan O; Gonen MS; Bilgir F; Kebapcilar L; Kulac E; Cinali T; Bilgir O
    Intern Med; 2011; 50(15):1529-35. PubMed ID: 21804277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble adhesion molecules in children and young adults with chronic renal failure treated conservatively.
    Musiał K; Zwolińska D; Berny U; Polak-Jonkisz D; Szprynger K; Szczepańska M
    Rocz Akad Med Bialymst; 2004; 49():209-12. PubMed ID: 15631345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive vascular damage in hypertension is associated with increased levels of circulating P-selectin.
    Verhaar MC; Beutler JJ; Gaillard CA; Koomans HA; Fijnheer R; Rabelink TJ
    J Hypertens; 1998 Jan; 16(1):45-50. PubMed ID: 9533416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells.
    Shen JS; Meng XL; Moore DF; Quirk JM; Shayman JA; Schiffmann R; Kaneski CR
    Mol Genet Metab; 2008 Nov; 95(3):163-8. PubMed ID: 18707907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Vascular Phenotype in Fabry Patients.
    Vujkovac AC; Vujkovac B; Novaković S; Števanec M; Šabovič M
    Angiology; 2021 May; 72(5):426-433. PubMed ID: 33342225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors.
    Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Horký K; Aschermann M
    J Hum Hypertens; 2002 Aug; 16(8):557-62. PubMed ID: 12149661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency.
    Elhadd TA; Abdu TA; Oxtoby J; Kennedy G; McLaren M; Neary R; Belch JJ; Clayton RN
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4223-32. PubMed ID: 11549653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of etanercept on serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor in patients with rheumatoid arthritis.
    Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
    Scand J Rheumatol; 2009; 38(6):439-44. PubMed ID: 19922018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement.
    Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S
    Clin Rheumatol; 2005 Apr; 24(2):111-6. PubMed ID: 15349798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term enzyme replacement therapy is associated with reduced proteinuria and preserved proximal tubular function in women with Fabry disease.
    Prabakaran T; Birn H; Bibby BM; Regeniter A; Sørensen SS; Feldt-Rasmussen U; Nielsen R; Christensen EI
    Nephrol Dial Transplant; 2014 Mar; 29(3):619-25. PubMed ID: 24215016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for severe clinical events in male and female patients with Fabry disease treated with agalsidase beta enzyme replacement therapy: Data from the Fabry Registry.
    Hopkin RJ; Cabrera G; Charrow J; Lemay R; Martins AM; Mauer M; Ortiz A; Patel MR; Sims K; Waldek S; Warnock DG; Wilcox WR
    Mol Genet Metab; 2016 Sep; 119(1-2):151-9. PubMed ID: 27510433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.